Last scanned
Domain Age
Daily Visitors
Global Rank
Updated:
Update on Janssen’s BACE Inhibitor Program | Janssen
Titusville, United States, May 17, 2018 - At Janssen, the safety and well-being of people who participate in our clinical trials are of utmost importance to us. For the past several years, we have been studying an investigational drug called a BACE inhibitor. The goal of this research is to slow cognitive decline in people at risk for Alzheimer’s dementia.
This website is hosted with Amazon Technologies Inc., which reserves the following IP addresses for earlytrial.com: 35.169.149.56. Moreover, DNS used with this website include ns1.jnj.com, ns3.jnj.com, ns5.jnj.com. Subnet identifier ranges from 35.152.0.0 to 35.183.255.255. Classless Inter-Domain Routing (CIDR) is 35.152.0.0/13, 35.176.0.0/13, 35.160.0.0/12. ARIN net type is Direct Allocation.
Last scanned
Domain Age
Daily Visitors
Global Rank
ns1.jnj.com
ns3.jnj.com
ns5.jnj.com
{{value}}
2015-07-07
2024-07-07
REDACTED FOR PRIVACY
KEY-SYSTEMS GMBH
info@domain-contact.org
{{value}}
The registrar of earlytrial.com is KEY-SYSTEMS GMBH and the name expires on 2024-07-07. According to open source data, you can reach the owner at info@domain-contact.org but please make sure you have a good reason for unsolicited messages. Their country of residence is Germany.
58.2K
5.3K
N/A
N/A
N/A
N/A
61.1K
2.1K
N/A
N/A